Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MyoKardia, Inc.MYOK · Entity 145206 | Director | June 14, 2017 | June 16, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MyoKardia, Inc.
Report date June 14, 2017 · Filed June 16, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2027-06-13 | Direct | 11,000 |
Reported balance
After 2017-06-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-14 · Grant · Acquired 11,000 · Balance 11,000 F1: The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on July 14, 2017, such that this option is fully exercisable on June 14, 2018. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on July 14, 2017, such that this option is fully exercisable on June 14, 2018. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DEXCOM INC
Report date May 08, 2025 · Filed May 12, 2025
Section 16 reporting ended · disclosed 2025-05-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-05-08 transaction · row 1
1 source rowRow 1 · 2025-05-08 · Gift · Disposed 2,618 · Balance 0 F1: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. |
| Common StockSEC Table I · non-derivative | IndirectFamily Holdings | 380,545 |
Reported balance
After 2025-05-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-05-08 · Gift · Acquired 2,618 · Balance 380,545 F1: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F2: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units.
F2: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2025 Filed May 12, 2025 20:07 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000146 · wk-form4_1747080434.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Holdings Disclosed balance after: 380,545 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F2 · ownership.nature: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:07 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000146 · wk-form4_1747080434.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:41 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000119 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,618 F1 · shares: The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 18, 2024 Filed May 21, 2024 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000097 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Holdings Disclosed balance after: 377,927 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F2 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 18, 2024 Filed May 21, 2024 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 2,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000097 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 3,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000135 · edgardoc.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Holdings Disclosed balance after: 375,016 F2 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F3 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 3,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000135 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,911 F2 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,911 | $0.00 | $2.91 |
DisclosureSEC source: 0001093557-23-000135 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,863 F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:08 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 988 | $0.00 | $0.99 |
DisclosureSEC source: 0001093557-22-000122 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988 F2 · shares: The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 988 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Read SEC document |
| May 19, 2022 Filed May 23, 2022 21:08 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 919 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-22-000122 · edgardoc.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 92,766 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 19, 2022 Filed May 23, 2022 21:08 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 919 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-22-000122 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:57 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 919 | $0.00 | $0.92 |
DisclosureSEC source: 0001093557-21-000148 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919 F2 · shares: The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 919 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Read SEC document |
| May 20, 2021 Filed May 25, 2021 23:57 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000148 · edgardoc.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 91,847 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. F4 · ownership.nature: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 20, 2021 Filed May 25, 2021 23:57 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000148 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 22, 2020 Filed May 27, 2020 21:33 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 833 | $0.00 | $0.83 |
DisclosureSEC source: 0001093557-20-000163 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 F2 · shares: The RSU Award was granted on May 22, 2020 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 833 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Read SEC document |
| May 21, 2020 Filed May 27, 2020 21:33 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-20-000163 · edgardoc.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 91,014 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. F4 · ownership.nature: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 21, 2020 Filed May 27, 2020 21:33 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 2,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-20-000163 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:58 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,766 | $0.00 | $2.77 |
DisclosureSEC source: 0001093557-19-000150 · wf-form4_155969268158615.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,766 F2 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 2,766 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:58 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000150 · wf-form4_155969268158615.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 88,248 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:58 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000150 · wf-form4_155969268158615.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 20,000 | $100.10 | $2,001,998.00 |
DisclosureSEC source: 0001093557-18-000123 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 84,562 F1 · price: This transaction was executed in multiple trades at prices ranging from $99.75 to $100.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| June 01, 2018 Filed Jun 27, 2018 00:14 UTC Amendment | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 3,686 | $0.00 | $3.69 |
DisclosureSEC source: 0001093557-18-000139 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,686 F1 · shares: The RSU Award was granted on June 1, 2018 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. commom stock upon settlement. Read SEC document |
| June 01, 2018 Filed Feb 15, 2019 21:57 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 4,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000026 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 104,562 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| June 01, 2018 Filed Feb 15, 2019 21:57 UTC | DEXCOM INC DXCM · Entity 3114 | OtherCommon Stock | 4,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000026 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:02 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 3,695 | $0.00 | $3.70 |
DisclosureSEC source: 0001093557-18-000114 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,348 F1 · security: Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. commom stock upon settlement. F2 · shares: The RSU Award was granted on May 31, 2018 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting. F3 · balance_after: Represents 8,348 restricted stock units, 4,653 of which were granted on June 1, 2017 and shall vest on June 1, 2018 and 3,695 of which were granted on May 31, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 16:11 UTC | MyoKardia, Inc. MYOK · Entity 145206 | GrantStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0000899243-17-016561 · doc4.xml · derivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2027-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on July 14, 2017, such that this option is fully exercisable on June 14, 2018. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan). Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:47 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 4,653 | $0.00 | $4.65 |
DisclosureSEC source: 0001093557-17-000143 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,653 F1 · shares: Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.